View all cases
UPC CFI 439/2025
May 19, 2025·EP3175863 · VARIANTS OF C-TYPE NATRIURETIC PEPTIDE
- Case details
- StatusCase Closed (Withdrawn)ActionCounterclaim for revocationCategoryCounterclaim for revocation
- Parties
- Claimants
- Ascendis Pharma Growth Disorders A/SOperating co.
- Ascendis Pharma A/SOperating co.
Representatives- Daniel Wise-Carpmaels & Ransford
- Agathe Michel-De Cazotte-Carpmaels & Ransford
- Anna Leathley-Carpmaels & Ransford
- Daniel Wiese-Carpmaels & Ransford
Respondents- BioMarin Pharmaceutical Inc.Operating co.
Representatives- Christian Paul-Jones Day
- Tobias Mandler-Jones Day
- Pascal Grandé-Jones Day
- Olga Bezzubova-Jones Day
- Ping Li-Jones Day
- Sven Rihm-Jones Day
- Jason Raeburnsupporting-PAUL HASTINGS
- Alex Morgansupporting-PAUL HASTINGS
- Division
- Munich LD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- InstrumentsAnalysis of biological materials
- Language
- English
- EPO Opposition
- Ascendis Pharma Growth Disorders A/SAdmissible2022-09-01
- ASCENDIS PHARMA A/SIntervention2025-04-10
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
| Patent revoked | Median days to first decision | |
|---|---|---|
| All UPC | 37% (34/91) | 124 |
| Munich LD | Locked | Locked |
| Judge Matthias Zigann | Locked | Locked |
| Judge András Kupecz | Locked | Locked |
| Judge Tobias Pichlmaier | Locked | Locked |
| Judge Eric Enderlin | Locked | Locked |
At the UPC: Ascendis Pharma Growth Disorders A/S (3 cases)·BioMarin Pharmaceutical Inc. (3 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 2 other proceedings
Decisions
- —infringement
Summary: 2. The withdrawal of the infringement action by the Claimant and the counterclaim action by the Defendants, actions UPC_CFI_18/2025 and UPC_CFI_439/2025, respectively, are permitted. 3. The Proceedings are declared closed.
Documents
| Document title | Date | Public |
|---|---|---|
| Case closed | 2025-12-29 | Not public |
| Decision | 2025-12-29 | Public |
| Decision | 2025-12-29 | Not public |
| Decision | 2025-12-29 | Not public |
| Order | 2025-10-24 | Not public |
| Order | 2025-10-24 | Not public |
| EPO_Communication_check_Outcome | 2025-08-11 | Not public |
| Hearing-Dates | 2025-07-30 | Not public |
| scheduling - final | 2025-07-30 | Public |
| Hearing-Dates | 2025-07-30 | Not public |
| Acknowledgement-of-lodging | 2025-07-24 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-24 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-24 | Not public |
| Acknowledgement-of-lodging | 2025-07-23 | Not public |
| Exhibit MR - AR1 maintained in opposition | 2025-07-23 | Not public |
| Exhibit JD 45-1 - Exhibits Prof. Wilcox | 2025-07-23 | Not public |
| Exhibit JD 39-1 - Exhibits Prof. Pasut Part 1 | 2025-07-23 | Not public |
| Exhibit JD 16 - Technology primer | 2025-07-23 | Not public |
| Exhibit AR 2 - Conjugate without linkage in claim 1 | 2025-07-23 | Not public |
| Exhibit JD 15 - Opposition decision EP 863 | 2025-07-23 | Not public |
| Exhibit JD 46 - Reports on NEP cleavage of larger peptides | 2025-07-23 | Not public |
| Exhibit JD 13 - EP 3 175 863 B1 | 2025-07-23 | Not public |
| Exhibit JD 45 - Expert Declaration Prof. Wilcox | 2025-07-23 | Not public |
| Exhibit JD 39-2 - Exhibits Prof. Pasut Part 2 | 2025-07-23 | Not public |
| Exhibit AR 4 - MR and Disclaimer | 2025-07-23 | Not public |
| Exhibit AR 1 - Conjugate | 2025-07-23 | Not public |
| Exhibit JD 39 - Expert Declaration Prof. Pasut | 2025-07-23 | Not public |
| Exhibit AR 3 - Conjugate without linkage complete | 2025-07-23 | Not public |
| Statement of Defence against the Counterclaim for Revocation | 2025-07-23 | Not public |
| Exhibit MR - AR1 maintained in opposition | 2025-07-23 | Not public |
| BioMarin vs Ascendis - Application to amend a patent | 2025-07-23 | Not public |
| Exhibit AR 4 - MR and Disclaimer | 2025-07-23 | Not public |
| Exhibit AR 1 - Conjugate | 2025-07-23 | Not public |
| Exhibit AR 2 - Conjugate without linkage in claim 1 | 2025-07-23 | Not public |
| Exhibit AR 3 - Conjugate without linkage complete | 2025-07-23 | Not public |
| Panel-Appointment | 2025-07-08 | Not public |
| Notification Of Service | 2025-06-26 | Not public |
| Access to case | 2025-06-26 | Not public |
| Acknowledgement of access to case | 2025-06-11 | Not public |
| Document from EPO | 2025-05-28 | Not public |
| Letter-for-Service | 2025-05-27 | Not public |
| Panel-Appointment | 2025-05-27 | Not public |
| EPO-Request-for-case-pending | 2025-05-27 | Not public |
| Acknowledgement-of-lodging | 2025-05-27 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-05-27 | Not public |
| Exhibit CR-39.2 | 2025-05-19 | Not public |
| Exhibit CR-15 | 2025-05-19 | Not public |
| Exhibit CR-23 | 2025-05-19 | Not public |
| Exhibit CR-05 | 2025-05-19 | Not public |
| Exhibit CR-37 | 2025-05-19 | Not public |
| Exhibit CR-22 | 2025-05-19 | Not public |
| Exhibit CR-10 | 2025-05-19 | Not public |
| Exhibit CR-30 | 2025-05-19 | Not public |
| Exhibit CR-48.1 | 2025-05-19 | Not public |
| Exhibit CR-29 | 2025-05-19 | Not public |
| Exhibit CR-39.1 | 2025-05-19 | Not public |
| Exhibit CR-06 | 2025-05-19 | Not public |
| Exhibit CR-45 | 2025-05-19 | Not public |
| Exhibit CR-42 | 2025-05-19 | Not public |
| Proof of payment | 2025-05-19 | Not public |
| Exhibit CR-31.1 | 2025-05-19 | Not public |
| Exhibit CR-48 | 2025-05-19 | Not public |
| Exhibit CR-14 | 2025-05-19 | Not public |
| Exhibit CR-41 | 2025-05-19 | Not public |
| Exhibit CR-44 | 2025-05-19 | Not public |
| Statement of Defence | 2025-05-19 | Not public |
| Exhibit CR-32 | 2025-05-19 | Not public |
| Exhibit CR-08 | 2025-05-19 | Not public |
| Exhibit CR-35 | 2025-05-19 | Not public |
| Exhibit CR-39.3 | 2025-05-19 | Not public |
| Exhibit CR-16 | 2025-05-19 | Not public |
| Exhibit CR-46 | 2025-05-19 | Not public |
| Exhibit CR-31.2 | 2025-05-19 | Not public |
| Exhibit CR-07 | 2025-05-19 | Not public |
| Exhibit CR-09 | 2025-05-19 | Not public |
| Exhibit CR-38 | 2025-05-19 | Not public |
| Exhibit CR-18 | 2025-05-19 | Not public |
| Exhibit CR-21 | 2025-05-19 | Not public |
| Exhibit CR-39.4 | 2025-05-19 | Not public |
| Exhibit CR-43 | 2025-05-19 | Not public |
| Exhibit CR-04 | 2025-05-19 | Not public |
| Exhibit CR-33 | 2025-05-19 | Not public |
| Exhibit CR-03 | 2025-05-19 | Not public |
| Exhibit CR-36 | 2025-05-19 | Not public |
| Exhibit CR-01 | 2025-05-19 | Not public |
| Exhibit CR-34 | 2025-05-19 | Not public |
| Exhibit CR-17.2 | 2025-05-19 | Not public |
| Exhibit CR-40 | 2025-05-19 | Not public |
| Exhibit CR-17.1 | 2025-05-19 | Not public |
| Exhibit CR-11 | 2025-05-19 | Not public |
| Exhibit CR-20 | 2025-05-19 | Not public |
| Exhibit CR-47 | 2025-05-19 | Not public |
| Exhibit CR-12 | 2025-05-19 | Not public |
| Exhibit CR-19 | 2025-05-19 | Not public |
| Exhibit CR-13 | 2025-05-19 | Not public |
| Exhibit CR-02 | 2025-05-19 | Not public |